EKF Diagnostics Holdings Plc - Asset Resilience Ratio
EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EKF Diagnostics Holdings Plc (EKF) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. See EKF equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of EKF Diagnostics Holdings Plc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-1.29 Million | -1.58% |
| Total Liquid Assets | GBX-1.29 Million | -1.58% |
Asset Resilience Insights
- Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio
Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)
The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | -1.58% | GBX-1.29 Million ≈ $-156.83 |
GBX81.75 Million ≈ $9.95K |
-1.66pp |
| 2011-12-31 | 0.09% | GBX51.00K ≈ $6.21 |
GBX58.73 Million ≈ $7.15K |
-0.19pp |
| 2010-12-31 | 0.28% | GBX100.00K ≈ $12.17 |
GBX35.98 Million ≈ $4.38K |
-7.12pp |
| 2009-12-31 | 7.39% | GBX473.00K ≈ $57.55 |
GBX6.40 Million ≈ $778.33 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more